Twenty patients presenting acute ischemic stroke will be randomized in a 1:1 proportion to treatment with allogeneic MSCs from adipose tissue or to placebo ( or vehicle ) administered as a single intravenous dose within the first 2 weeks after the onset of stroke symptoms .